Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety
C
Christopher E. Goldring
G
Giusy Russomanno
C
Carmen Pin
P
Panuwat Trairatphisan
K
Kylie A. Beattie
C
Ciarán P. Fisher
J
Janet Piñero
R
Richard J. Brennan
D
Diana Clausznitzer
I
Ian M. Copple
T
Theo M. de Kok
C
Carrie A. Duckworth
L
Laura I. Furlong
B
Barbara Füzi
A
Attila Gabor
L
Louis Gall
J
Jan Hengstler
H
Henning Hermjakob
F
Fiona Hunter
D
Danyel Jennen
M
Mikko Koskinen
S
Steven J. Kunnen
L
Lieve Lammens
S
Sebastian Lobentanzer
M
Marcel Mohr
E
Elisa Passini
D
D. Mark Pritchard
R
Rahuman S. Malik-Sheriff
B
Blanca Rodríguez
E
Eric I. Rossman
J
Julio Saez-Rodríguez
F
Friedemann Schmidt
R
Rowena Sison-Young
I
Inari Soininen
S
Sean Turner
B
Bob van de Water
J
Johan G. C. van Hasselt
F
Filippo Venezia
J
Jeffrey A. Willy
D
Derek J. Leishman
J
James L. Stevens
L
Loic Laplanche
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 25, Issue 2
Published
February 01, 2026
Pages
138-153
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (42)
C
Christopher E. Goldring
G
Giusy Russomanno
C
Carmen Pin
P
Panuwat Trairatphisan
K
Kylie A. Beattie
C
Ciarán P. Fisher
J
Janet Piñero
R
Richard J. Brennan
D
Diana Clausznitzer
I
Ian M. Copple
T
Theo M. de Kok
C
Carrie A. Duckworth
L
Laura I. Furlong
B
Barbara Füzi
A
Attila Gabor
L
Louis Gall
J
Jan Hengstler
H
Henning Hermjakob
F
Fiona Hunter
D
Danyel Jennen
M
Mikko Koskinen
S
Steven J. Kunnen
L
Lieve Lammens
S
Sebastian Lobentanzer
M
Marcel Mohr
E
Elisa Passini
D
D. Mark Pritchard
R
Rahuman S. Malik-Sheriff
B
Blanca Rodríguez
E
Eric I. Rossman
J
Julio Saez-Rodríguez
F
Friedemann Schmidt
R
Rowena Sison-Young
I
Inari Soininen
S
Sean Turner
B
Bob van de Water
J
Johan G. C. van Hasselt
F
Filippo Venezia
J
Jeffrey A. Willy
D
Derek J. Leishman
J
James L. Stevens
L
Loic Laplanche
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w